Investor Alert

New York Markets Close in:

July 2, 2020, 5:24 a.m. EDT

Thoracic Outlet Syndrome Market Share and Growth Factors Impact Analysis 2020 - 2027

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Jul 02, 2020 (Profound via COMTEX) -- Thoracic outlet syndrome is a group of heterogeneous and disabling upper-extremity disorders that occur due to extrinsic compression of neurovascular structures between the clavicle and the first rib. There are three distinct types of thoracic outlet syndrome viz. neurogenic thoracic outlet syndrome, venous thoracic outlet syndrome, and arterial thoracic outlet syndrome. Neurogenic thoracic outlet syndrome is most common, i.e., it constitutes around 85%-90% of thoracic outlet syndrome cases. Venous thoracic outlet syndrome constitutes around 10%-15% of thoracic outlet syndrome cases, whereas arterial thoracic outlet syndrome is found in 2%-5% of thoracic outlet syndrome cases.

Rising cases of trauma and car accidents are boosting the growth of the thoracic outlet syndrome market. Chest injury is one of the causes of thoracic outlet syndrome, and this comes about as a result of traffic accidents in which the collarbone is broken, and the upper ribs are injured. As per the World Health Organization (WHO) report, nearly 20-50 million people incur non-fatal injuries as a result of road traffic accidents.

Download Sample - https://www.novaoneadvisor.com/report/sample/2324


The thoracic outlet syndrome market is segmented on the basis of type, diagnosis, treatment, and end-user.

On the basis of type, the market is segmented into neurogenic thoracic outlet syndrome, venous thoracic outlet syndrome, and arterial thoracic outlet syndrome.

On the basis of diagnosis, the market is segmented into nerve conduction studies, vascular studies, chest X-ray, cervical spine X-rays, computed tomography (CT) scan, magnetic resonance imaging (MRI), and magnetic resonance imaging with angiography (MRA), arteriogram/venogram, and blood tests.

On the basis of treatment, the market is segmented into surgery, medications, physical therapy, and others. The medications segment is further classified into muscle relaxant, thrombolytic medications, anticoagulant medications, and others.

On the basis of end-user, the market is segmented into hospital amp; Clinics, diagnostic centers, academic and research institutes, drug pharmacies, and others.
Key Players

Some of key the players in the market are Abbott Laboratories, Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Endo Pharmaceuticals, Inc., Johnson amp; Johnson Services, Inc., Mallinckrodt plc., Orient Pharma Co., Ltd., Par Sterile Products, LLC., Sanofi, SteriMax Inc., Upsher Smith Laboratories, Inc., Vertical Pharmaceuticals LLC, and others.

Download Full Report - https://www.novaoneadvisor.com/report/checkout/2324

PDF File Dispatch Time - 24 Hours. We Will also support Word, PPT, Excel Files Dispatch

Contact Us:

Nova One Advisor

URL - https://www.novaoneadvisor.com/

Mailing Address: 237 West 35th Street,Suite 605,New York, NY 10001, USA

Any Assistance, Email ndash; sales@novaoneadvisor.com


Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.